Publications
Selected publications
- Outcomes of first emergency admissions for alcohol-related liver disease in England over a 10-year period: retrospective observational cohort study using linked electronic databases. (Journal article - 2023)
- Validation of the IBD-Control Questionnaire across different sociodemographic and clinical subgroups: Secondary analysis of a nationwide electronic survey (Journal article - 2023)
- Reducing variation in hospital mortality for alcohol-related liver disease in North West England (Journal article - 2020)
- Heterogeneity in outcome assessment for inflammatory bowel disease in routine clinical practice: a mixed-methods study in a sample of English hospitals (Journal article - 2021)
- Nationwide improvement in outcomes of emergency admission for ulcerative colitis in England, 2005‐2013 (Journal article - 2019)
- Systematic Review: Outcomes and Adverse Events From Randomised Trials in Crohn's Disease (Journal article - 2019)
- Value Assessment and Quantitative Benefit-Risk Modelling of Biosimilar Infliximab for Crohn's Disease (Journal article - 2019)
- Development and validation of a rapid, generic measure of disease control from the patient's perspective: The IBD-Control questionnaire (Journal article - 2014)
- Cost-effectiveness of biological therapy for Crohn's disease: Markov cohort analyses incorporating United Kingdom patient-level cost data (Journal article - 2009)
- Cost of illness of inflammatory bowel disease in the UK: a single centre retrospective study (Journal article - 2004)
2023
Outcomes of first emergency admissions for alcohol-related liver disease in England over a 10-year period: retrospective observational cohort study using linked electronic databases.
Bodger, K., Mair, T., Schofield, P., Silberberg, B., Hood, S., & Fleming, K. M. (2023). Outcomes of first emergency admissions for alcohol-related liver disease in England over a 10-year period: retrospective observational cohort study using linked electronic databases.. BMJ open, 13(11), e076955. doi:10.1136/bmjopen-2023-076955
Validation of the IBD-Control Questionnaire across different sociodemographic and clinical subgroups: Secondary analysis of a nationwide electronic survey
Gebeyehu, G., Taylor, F., Dobson, E., Cummings, F., Bloom, S., Kennedy, N., . . . Bodger, K. (2023). Validation of the IBD-Control Questionnaire across different sociodemographic and clinical subgroups: Secondary analysis of a nationwide electronic survey. Journal of Crohn's and Colitis. doi:10.1093/ecco-jcc/jjad147
Establishing key performance indicators for inflammatory bowel disease in the UK
Quraishi, M. N., Dobson, E., Ainley, R., Din, S., Wakeman, R., Cummings, F., . . . Selinger, C. P. (2023). Establishing key performance indicators for inflammatory bowel disease in the UK. FRONTLINE GASTROENTEROLOGY. doi:10.1136/flgastro-2023-102409
Editorial: the burden of alcohol-related liver disease emergency admissions in England may be twice as high as previously thought-authors' reply
Bodger, K., & Dhanda, A. (2023). Editorial: the burden of alcohol-related liver disease emergency admissions in England may be twice as high as previously thought-authors' reply. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 57(4), 437-438. doi:10.1111/apt.17366
The Liverpool alcohol-related liver disease algorithm identifies twice as many emergency admissions compared to standard methods when applied to Hospital Episode Statistics for England
Dhanda, A., Bodger, K., Hood, S., Henn, C., Allison, M., Amasiatu, C., . . . White, M. (2023). The Liverpool alcohol-related liver disease algorithm identifies twice as many emergency admissions compared to standard methods when applied to Hospital Episode Statistics for England. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 57(4), 368-377. doi:10.1111/apt.17307
Implementing electronic patient reported outcomes in inflammatory bowel disease: patient participation, score reliability and validity.
Deutscher, D., Weil, C., Chodick, G., Tsukinovsky, S., Bodger, K., Waterman, M., & Kariv, R. (2023). Implementing electronic patient reported outcomes in inflammatory bowel disease: patient participation, score reliability and validity.. Health and quality of life outcomes, 21(1), 2. doi:10.1186/s12955-023-02087-0
2022
Patient-reported Outcomes: the ICHOM Standard Set for Inflammatory Bowel Disease in Real-life Practice Helps Quantify Deficits in Current Care
Wong, D., Matini, L., Kormilitzin, A., Kantschuster, R., Simadibrata, D. M., Lyden, S., . . . Walsh, A. (2022). Patient-reported Outcomes: the ICHOM Standard Set for Inflammatory Bowel Disease in Real-life Practice Helps Quantify Deficits in Current Care. JOURNAL OF CROHNS & COLITIS, 16(12), 1874-1881. doi:10.1093/ecco-jcc/jjac099
Editorial: rising rates of venous thromboembolism among hospitalised patients with inflammatory bowel disease in the USA
Bodger, K. (2022). Editorial: rising rates of venous thromboembolism among hospitalised patients with inflammatory bowel disease in the USA. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 56(7), 1211-1212. doi:10.1111/apt.17196
2021
Heterogeneity in outcome assessment for inflammatory bowel disease in routine clinical practice: a mixed-methods study in a sample of English hospitals
Razanskaite, V., Kallis, C., Young, B., Williamson, P. R., & Bodger, K. (2021). Heterogeneity in outcome assessment for inflammatory bowel disease in routine clinical practice: a mixed-methods study in a sample of English hospitals. BMJ OPEN, 11(12). doi:10.1136/bmjopen-2021-056413
Efficacy and safety of elective switching of inflammatory bowel disease patients from intravenous to subcutaneous infliximab (IFX): a multi-centre cohort study
Smith, P. J., Storey, D., Gregg, B., Critchley, L., Stenson, J., Kneebone, A., . . . Subramanian, S. (2021). Efficacy and safety of elective switching of inflammatory bowel disease patients from intravenous to subcutaneous infliximab (IFX): a multi-centre cohort study. In JOURNAL OF CROHNS & COLITIS Vol. 15 (pp. S480-S481). doi:10.1093/ecco-jcc/jjab076.619
Editorial: time trends in colectomy rates for ulcerative colitis in England-mixed methods brings mixed messages?
Bodger, K. (2021). Editorial: time trends in colectomy rates for ulcerative colitis in England-mixed methods brings mixed messages?. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 53(5), 660. doi:10.1111/apt.16243
2020
Comparative effectiveness of ustekinumab or vedolizumab after one year in 130 patients with anti‐TNF‐refractory Crohn’s disease
Townsend, T., Razanskaite, V., Dodd, S., Storey, D., Michail, S., Morgan, J., . . . Subramanian, S. (2020). Comparative effectiveness of ustekinumab or vedolizumab after one year in 130 patients with anti‐TNF‐refractory Crohn’s disease. Alimentary Pharmacology and Therapeutics, 52(8), 1341-1352. doi:10.1111/apt.16057
Reducing variation in hospital mortality for alcohol-related liver disease in North West England
Kallis, C., Dixon, P., Silberberg, B., Affarah, L., Shawihdi, M., Grainger, R., . . . Bodger, K. (2020). Reducing variation in hospital mortality for alcohol-related liver disease in North West England. Alimentary Pharmacology and Therapeutics, 52(1), 182-195. doi:10.1111/apt.15781
Variation in assessment of outcomes for inflammatory bowel disease in routine clinical practice: a mixed-methods study
Razanskaite, V., Williamson, P., Young, B., & Bodger, K. (2020). Variation in assessment of outcomes for inflammatory bowel disease in routine clinical practice: a mixed-methods study. In JOURNAL OF CROHNS & COLITIS Vol. 14 (pp. S227). Retrieved from https://www.webofscience.com/
2019
Value Assessment and Quantitative Benefit-Risk Modelling of Biosimilar Infliximab for Crohn's Disease
Catt, H., Bodger, K., Kirkham, J. J., & Hughes, D. A. (2019). Value Assessment and Quantitative Benefit-Risk Modelling of Biosimilar Infliximab for Crohn's Disease. PHARMACOECONOMICS, 37(12), 1509-1523. doi:10.1007/s40273-019-00826-0
Nationwide improvement in outcomes of emergency admission for ulcerative colitis in England, 2005‐2013
Shawihdi, M., Dodd, S., Kallis, C., Dixon, P., Grainger, R., Bloom, S., . . . Bodger, K. (2019). Nationwide improvement in outcomes of emergency admission for ulcerative colitis in England, 2005‐2013. Alimentary Pharmacology and Therapeutics, 50(2), 176-192. doi:10.1111/apt.15315
Systematic Review: Outcomes and Adverse Events From Randomised Trials in Crohn's Disease
Catt, H., Hughes, D., Kirkham, J., & Bodger, K. (2019). Systematic Review: Outcomes and Adverse Events From Randomised Trials in Crohn's Disease. Alimentary Pharmacology and Therapeutics, 49(8), 978-996. doi:10.1111/apt.15174
Comparative effectiveness of vedolizumab and ustekinumab as induction therapy in anti-TNF refractory Crohn's disease: a multi-centre retrospective cohort study
Townsend, T., Razanskaite, V., Michail, S., Morgan, J., Davies, M., Storey, D., . . . Subramanian, S. (2019). Comparative effectiveness of vedolizumab and ustekinumab as induction therapy in anti-TNF refractory Crohn's disease: a multi-centre retrospective cohort study. In JOURNAL OF CROHNS & COLITIS Vol. 13 (pp. S407-S408). doi:10.1093/ecco-jcc/jjy222.710
Editorial: UK quality of care drive improving ulcerative colitis hospital outcomes. Author's reply
Bodger, K. (2019). Editorial: UK quality of care drive improving ulcerative colitis hospital outcomes. Author's reply. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 50(5), 602-603. doi:10.1111/apt.15444
2018
QUANTITATIVE BENEFIT-RISK MODELLING OF BIOSIMILARS: A CASE STUDY OF INFLIXIMAB IN CROHN'S DISEASE.
Catt, H., Bodger, K., Kirkham, J., & Hughes, D. A. (2018). QUANTITATIVE BENEFIT-RISK MODELLING OF BIOSIMILARS: A CASE STUDY OF INFLIXIMAB IN CROHN'S DISEASE.. In VALUE IN HEALTH Vol. 21 (pp. S380). doi:10.1016/j.jval.2018.09.2262
A SYSTEMATIC REVIEW OF OUTCOMES AND ADVERSE EVENTS FOR RANDOMISED CONTROLLED TRIALS IN CROHN'S DISEASE
Catt, M. H., Hughes, D., Bodger, K., & Kirkham, J. (2018). A SYSTEMATIC REVIEW OF OUTCOMES AND ADVERSE EVENTS FOR RANDOMISED CONTROLLED TRIALS IN CROHN'S DISEASE. In GUT Vol. 67 (pp. A71). doi:10.1136/gutjnl-2018-BSGAbstracts.139
ANALYSIS OF 140000 PATIENTS WITH BILE DUCT STONES PRESENTING TO ENGLISH ACUTE TRUSTS, 2013-2016
Delvincourt, M., Carter, J., Bodger, K., Webster, G., & Sturgess, R. (2018). ANALYSIS OF 140000 PATIENTS WITH BILE DUCT STONES PRESENTING TO ENGLISH ACUTE TRUSTS, 2013-2016. In GUT Vol. 67 (pp. A41). doi:10.1136/gutjnl-2018-BSGAbstracts.80
BENCHMARKING OF ACTIVITY, PROCESS AND OUTCOME OF EMERGENCY ADMISSION FOR ULCERATIVE COLITIS ACROSS ENGLISH HOSPITALS
Shawihdi, M., Dodd, S., Appelbe, D., Dixon, P., Grainger, R., Cummings, F., . . . Bodger, K. (2018). BENCHMARKING OF ACTIVITY, PROCESS AND OUTCOME OF EMERGENCY ADMISSION FOR ULCERATIVE COLITIS ACROSS ENGLISH HOSPITALS. In GUT Vol. 67 (pp. A222). doi:10.1136/gutjnl-2018-BSGAbstracts.442
GENERATING BETTER INFORMATION TO INFORM SERVICES FOR ALCOHOL-RELATED LIVER DISEASE: THE CONNECTED HEALTH CITIES PROGRAMME
Kallis, C., Dixon, P., Shawihdi, M., Jenkins, A., Silberberg, B., Abba, K., . . . Bodger, K. (2018). GENERATING BETTER INFORMATION TO INFORM SERVICES FOR ALCOHOL-RELATED LIVER DISEASE: THE CONNECTED HEALTH CITIES PROGRAMME. In GUT Vol. 67 (pp. A107). doi:10.1136/gutjnl-2018-BSGAbstracts.211
GROWTH IN PARTICIPATION, REGISTRATIONS AND DATA MATURITY IN THE UK IBD REGISTRY: FOCUS ON BIOLOGICS
Shawihdi, M., Razanskaite, V., Cummings, F., Bloom, S., Bodger, K., & Bodger, K. (2018). GROWTH IN PARTICIPATION, REGISTRATIONS AND DATA MATURITY IN THE UK IBD REGISTRY: FOCUS ON BIOLOGICS. In GUT Vol. 67 (pp. A56). doi:10.1136/gutjnl-2018-BSGAbstracts.111
MY-IBD PORTAL: PROGRESS AND IMPACT UPDATE
Mclaughlin, J., Stansfield, C., Lal, S., Bodger, K., & Robinson, J. A. (2018). MY-IBD PORTAL: PROGRESS AND IMPACT UPDATE. In GUT Vol. 67 (pp. A223). doi:10.1136/gutjnl-2018-BSGAbstracts.445
Developing a Standard Set of Patient-Centred Outcomes for Inflammatory Bowel Disease—an International, Cross-disciplinary Consensus
Kim, A. H., Roberts, C., Feagan, B. G., Banerjee, R., Bemelman, W., Bodger, K., . . . Travis, S. P. (2018). Developing a Standard Set of Patient-Centred Outcomes for Inflammatory Bowel Disease—an International, Cross-disciplinary Consensus. Journal of Crohn's & colitis, 12(04), 408-418. doi:10.1093/ecco-jcc/jjx161
Reduced risk of emergency admission for colorectal cancer associated with the introduction of bowel cancer screening across England: a retrospective national cohort study
Geraghty, J., Shawihdi, M., Devonport, E., Sarkar, S., Pearson, M. G., & Bodger, K. (2018). Reduced risk of emergency admission for colorectal cancer associated with the introduction of bowel cancer screening across England: a retrospective national cohort study. COLORECTAL DISEASE, 20(2), 94-104. doi:10.1111/codi.13822
2017
Roundtable on registries: practical considerations for registries - making them work, London, UK, 26 January 2017
Bloom, S., Bodger, K., Cummings, F., Garner, S., Hyrich, K., Jacklin, C., & Williams, J. G. (2017). Roundtable on registries: practical considerations for registries - making them work, London, UK, 26 January 2017. GABI JOURNAL-GENERICS AND BIOSIMILARS INITIATIVE JOURNAL, 6(3), 122-134. doi:10.5639/gabij.2017.0603.025
IMPROVED OUTCOMES OF EMERGENCY ADMISSION FOR ULCERATIVE COLITIS (UC) IN ENGLAND OVER THE LAST DECADE: A TEN YEAR ANALYSIS OF ROUTINE NHS DATA
Shawihdi, M., Dodd, S., Grainger, R., Bloom, S., Cummings, F., Driscoll, R., . . . Bodger, K. (2017). IMPROVED OUTCOMES OF EMERGENCY ADMISSION FOR ULCERATIVE COLITIS (UC) IN ENGLAND OVER THE LAST DECADE: A TEN YEAR ANALYSIS OF ROUTINE NHS DATA. In GUT Vol. 66 (pp. A254). doi:10.1136/gutjnl-2017-314472.495
INEQUALITY OF PROVISION OF INFLAMMATORY BOWEL DISEASE NURSES (IBD-N) ACROSS ENGLAND: CORRELATION WITH METRICS OF UNPLANNED HOSPITAL CARE FOR ADULT SERVICES
Shawihdi, M., Kneebone, A., & Bodger, K. (2017). INEQUALITY OF PROVISION OF INFLAMMATORY BOWEL DISEASE NURSES (IBD-N) ACROSS ENGLAND: CORRELATION WITH METRICS OF UNPLANNED HOSPITAL CARE FOR ADULT SERVICES. In GUT Vol. 66 (pp. A260). doi:10.1136/gutjnl-2017-314472.508
MONITORING UNPLANNED CARE AND SURGICAL EVENTS FOR CROHN'S DISEASE PATIENTS TREATED WITH BIOLOGICS IN ENGLAND: LINKAGE OF ROUTINE ADMINISTRATIVE DATA AND UK IBD REGISTRY
Shawihdi, M., Driscoll, R., Bloom, S., Cummings, F., Grainger, S., Johnson, M., . . . Bodger, K. (2017). MONITORING UNPLANNED CARE AND SURGICAL EVENTS FOR CROHN'S DISEASE PATIENTS TREATED WITH BIOLOGICS IN ENGLAND: LINKAGE OF ROUTINE ADMINISTRATIVE DATA AND UK IBD REGISTRY. In GUT Vol. 66 (pp. A251). doi:10.1136/gutjnl-2017-314472.489
DEFINING PATIENT-CENTERED OUTCOMES FOR IBD AND AN INTERNATIONAL, CROSS-DISCIPLINARY CONSENSUS
Kim, A. H., Roberts, C., Feagan, B. G., Banerjee, R., Bemelman, W., Bodger, K., . . . Travis, S. P. (2017). DEFINING PATIENT-CENTERED OUTCOMES FOR IBD AND AN INTERNATIONAL, CROSS-DISCIPLINARY CONSENSUS. In GASTROENTEROLOGY Vol. 152 (pp. S137-S138). doi:10.1016/S0016-5085(17)30791-6
Patient Reported Outcome Measures (PROMs) in Inflammatory Bowel Disease: New Data
Bojic, D., Bodger, K., & Travis, S. (2017). Patient Reported Outcome Measures (PROMs) in Inflammatory Bowel Disease: New Data. JOURNAL OF CROHNS & COLITIS, 11, S576-S585. doi:10.1093/ecco-jcc/jjw187
P241 Defining patient-centered outcomes for IBD - an international, cross-disciplinary consensus.
Kim, A., Roberts, C., Feagan, B., Banerjee, R., Bemelman, W., Bodger, K., . . . Travis, S. (2017). P241 Defining patient-centered outcomes for IBD - an international, cross-disciplinary consensus.. Journal of Crohn's & colitis, 11(suppl_1), S200.
Defining patient-centered outcomes for IBD - an international, cross-disciplinary consensus
Kim, A., Roberts, C., Feagan, B., Banerjee, R., Bemelman, W., Bodger, K., . . . Travis, S. (2017). Defining patient-centered outcomes for IBD - an international, cross-disciplinary consensus. In JOURNAL OF CROHNS & COLITIS Vol. 11 (pp. S200). Retrieved from https://www.webofscience.com/
Quantitative benefit-risk modelling of infliximab biosimilar inflectra versus reference product remicade in the treatment of Crohn's disease
Catt, H., Hughes, D., Bodger, K., & Kirkham, J. (2017). Quantitative benefit-risk modelling of infliximab biosimilar inflectra versus reference product remicade in the treatment of Crohn's disease. In TRIALS Vol. 18. Retrieved from https://www.webofscience.com/
2016
Commissioning for COPD care: a new, recordable metric that supports the patient interest
Walker, P. P., Thompson, E., Hill, S. L., Holton, K., Bodger, K., & Pearson, M. G. (2016). Commissioning for COPD care: a new, recordable metric that supports the patient interest. JOURNAL OF PUBLIC HEALTH, 38(2), 396-402. doi:10.1093/pubmed/fdv056
DEVELOPMENT OF INFORMATICS TOOLS FOR THE UK IBD REGISTRY USING ROUTINE DATA: PROFILING OF NATIONAL-LEVEL HOSPITAL ACTIVITY FOR IBD PATIENTS IN ENGLAND
Shawihdi, M., Osborne, A., Devonport, E., Driscoll, R., Cummings, F., Bloom, S., . . . Bodger, K. (2016). DEVELOPMENT OF INFORMATICS TOOLS FOR THE UK IBD REGISTRY USING ROUTINE DATA: PROFILING OF NATIONAL-LEVEL HOSPITAL ACTIVITY FOR IBD PATIENTS IN ENGLAND. In GUT Vol. 65 (pp. A208-A209). doi:10.1136/gutjnl-2016-312388.388
TRENDS IN MORTALITY FOR IBD PATIENTS ADMITTED AS AN EMERGENCY TO ENGLISH HOSPITALS: A 10-YEAR ANALYSIS OF ROUTINE ADMINISTRATIVE DATA
Shawihdi, M., Driscoll, R., Pearson, M., Cummings, F., Bloom, S., Williamson, P., & Bodger, K. (2016). TRENDS IN MORTALITY FOR IBD PATIENTS ADMITTED AS AN EMERGENCY TO ENGLISH HOSPITALS: A 10-YEAR ANALYSIS OF ROUTINE ADMINISTRATIVE DATA. In GUT Vol. 65 (pp. A83-A84). doi:10.1136/gutjnl-2016-312388.149
Referral patterns after a seizure admission in an English region: an opportunity for effective intervention? An observational study of routine hospital data
Grainger, R., Pearson, M., Dixon, P., Devonport, E., Timoney, M., Bodger, K., . . . Marson, A. (2016). Referral patterns after a seizure admission in an English region: an opportunity for effective intervention? An observational study of routine hospital data. BMJ OPEN, 6(1). doi:10.1136/bmjopen-2015-010100
2015
DEVELOPMENT OF DATA LINKAGE TECHNIQUES TO SUPPORT THE UK IBD REGISTRY: MAKING THE MOST OF ROUTINE NHS DATASETS
Bodger, K., Shawihdi, M., Pearson, M., Driscoll, R., Cummings, F., & Bloom, S. (2015). DEVELOPMENT OF DATA LINKAGE TECHNIQUES TO SUPPORT THE UK IBD REGISTRY: MAKING THE MOST OF ROUTINE NHS DATASETS. In GUT Vol. 64 (pp. A234-A235). doi:10.1136/gutjnl-2015-309861.502
FACTORS ASSOCIATED WITH RATING OF CARE AND THE FAMILY AND FRIENDS TEST: SECONDARY ANALYSIS OF THE UK IBD AUDIT INPATIENT EXPERIENCE SURVEY
Gledhill, T., & Bodger, K. (2015). FACTORS ASSOCIATED WITH RATING OF CARE AND THE FAMILY AND FRIENDS TEST: SECONDARY ANALYSIS OF THE UK IBD AUDIT INPATIENT EXPERIENCE SURVEY. In GUT Vol. 64 (pp. A442-A443). doi:10.1136/gutjnl-2015-309861.970
INDEPENDENT VALIDATION OF THE IBD-CONTROL QUESTIONNAIRE: RESULTS FROM A LARGE-SCALE ELECTRONIC PATIENT EXPERIENCE SURVEY (IBD2020)
Bodger, K., Gledhill, T., Driscoll, R., Terry, H., Irving, P., & Travis, S. (2015). INDEPENDENT VALIDATION OF THE IBD-CONTROL QUESTIONNAIRE: RESULTS FROM A LARGE-SCALE ELECTRONIC PATIENT EXPERIENCE SURVEY (IBD2020). In GUT Vol. 64 (pp. A235). doi:10.1136/gutjnl-2015-309861.503
2014
Optimising faecal occult blood screening: retrospective analysis of NHS Bowel Cancer Screening data to improve the screening algorithm
Geraghty, J., Butler, P., Seaman, H., Snowball, J., Sarkar, S., Blanks, R., . . . Rees, C. J. (2014). Optimising faecal occult blood screening: retrospective analysis of NHS Bowel Cancer Screening data to improve the screening algorithm. BRITISH JOURNAL OF CANCER, 111(11), 2156-2162. doi:10.1038/bjc.2014.480
Development and validation of a rapid, generic measure of disease control from the patient's perspective: The IBD-Control questionnaire
Bodger, K., Ormerod, C., Shackcloth, D., Harrison, M., & Collaborative, I. B. D. C. (2014). Development and validation of a rapid, generic measure of disease control from the patient's perspective: The IBD-Control questionnaire. Gut, 63(7), 1092-1102. doi:10.1136/gutjnl-2013-305600
EMERGENCY ADMISSIONS FOR ALCOHOL RELATED CONDITIONS: MAKING SENSE OF ROUTINE DATA
Lekharaju, P., Thompson, E., Shawihdi, M., Pearson, M., Hood, S., & Bodger, K. (2014). EMERGENCY ADMISSIONS FOR ALCOHOL RELATED CONDITIONS: MAKING SENSE OF ROUTINE DATA. In GUT Vol. 63 (pp. A236). doi:10.1136/gutjnl-2014-307263.508
NATIONWIDE STUDY OF EMERGENCY ADMISSIONS TO ACUTE HOSPITALS IN ENGLAND FOR ANOREXIA NERVOSA: IMPLICATIONS FOR MARSIPAN
Shawihdi, M., Thompson, E., Sharma, S., Lal, S., Pearson, M., & Bodger, K. (2014). NATIONWIDE STUDY OF EMERGENCY ADMISSIONS TO ACUTE HOSPITALS IN ENGLAND FOR ANOREXIA NERVOSA: IMPLICATIONS FOR MARSIPAN. In GUT Vol. 63 (pp. A275-A276). doi:10.1136/gutjnl-2014-307263.590
REDUCED RISK OF EMERGENCY ADMISSION FOR COLORECTAL CANCER ASSOCIATED WITH INTRODUCTION OF BOWEL CANCER SCREENING ACROSS ENGLAND: RETROSPECTIVE NATIONAL COHORT STUDY
Geraghty, J., Shawihdi, M., Thompson, E., Sarkar, S., Pearson, M., & Bodger, K. (2014). REDUCED RISK OF EMERGENCY ADMISSION FOR COLORECTAL CANCER ASSOCIATED WITH INTRODUCTION OF BOWEL CANCER SCREENING ACROSS ENGLAND: RETROSPECTIVE NATIONAL COHORT STUDY. GUT, 63, A22. doi:10.1136/gutjnl-2014-307263.45
THE IBD-CONTROL QUESTIONNAIRE: MULTI-CENTRE VALIDATION PLUS EVALUATION IN ROUTINE CARE
Gledhill, T., Brown, E., Collins, B., Subramanian, S., Bassi, A., & Bodger, K. (2014). THE IBD-CONTROL QUESTIONNAIRE: MULTI-CENTRE VALIDATION PLUS EVALUATION IN ROUTINE CARE. In GUT Vol. 63 (pp. A174-A175). doi:10.1136/gutjnl-2014-307263.374
Endoscopic balloon dilation of Crohn's disease strictures: Results from a large UK series
Bhalme, M., Sarkar, S., Lal, S., Bodger, K., Baker, R., Willert, R., & CERT-N, C. (2014). Endoscopic balloon dilation of Crohn's disease strictures: Results from a large UK series. Inflammatory Bowel Diseases, 20(2), 265-270. doi:10.1097/01.MIB.0000439067.76964.53
Variation in gastroscopy rate in English general practice and outcome for oesophagogastric cancer: retrospective analysis of Hospital Episode Statistics
Shawihdi, M., Thompson, E., Kapoor, N., Powell, G., Sturgess, R., Stern, N., . . . Bodger, K. (2014). Variation in gastroscopy rate in English general practice and outcome for oesophagogastric cancer: retrospective analysis of Hospital Episode Statistics. Gut, 63(2), 250-261. doi:10.1136/gutjnl-2012-304202
Management of large bowel obstruction with self-expanding metal stents. A multicentre retrospective study of factors determining outcome
Geraghty, J., Sarkar, S., Cox, T., Lal, S., Willert, R., Ramesh, J., . . . Carlson, G. L. (2014). Management of large bowel obstruction with self-expanding metal stents. A multicentre retrospective study of factors determining outcome. COLORECTAL DISEASE, 16(6), 476-483. doi:10.1111/codi.12582
Medical resource utilization and associated costs in patients with ulcerative colitis in the UK: a chart review analysis
Bodger, K., Yen, L., Szende, A., Sharma, G., Chen, Y. J., McDermott, J., & Hodgkins, P. (2014). Medical resource utilization and associated costs in patients with ulcerative colitis in the UK: a chart review analysis. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 26(2), 213-221. doi:10.1097/01.meg.0000435545.49133.cd
Variation in referral practice and differential cancer outcome: a strong reason to reflect on whether current guidelines are fit for purpose or implemented effectively in primary care
Bodger, K., & Shawihdi, M. (2014). Variation in referral practice and differential cancer outcome: a strong reason to reflect on whether current guidelines are fit for purpose or implemented effectively in primary care. GUT, 63(4), 703-704. doi:10.1136/gutjnl-2013-305775
2013
New and emerging treatments for ulcerative colitis: a focus on vedolizumab.
Gledhill, T., & Bodger, K. (2013). New and emerging treatments for ulcerative colitis: a focus on vedolizumab.. Biologics : targets & therapy, 7, 123-130. doi:10.2147/btt.s30416
Cross sectional study to determine Health-Related Quality of Life values in people with ulcerative colitis compared to population controls
Swinburn, S., Bean, K., Breheny, K., Lloyd, A., Curry, A., & Bodger, K. (2013). Cross sectional study to determine Health-Related Quality of Life values in people with ulcerative colitis compared to population controls. Submitted to TBC.
2012
A multicentre study to determine the incidence, demographics, aetiology and outcomes of 6-day emergency readmission following day-case endoscopy
Sarkar, S., Geraghty, J., Moore, A. R., Lal, S., Ramesh, J., & Bodger, K. (2012). A multicentre study to determine the incidence, demographics, aetiology and outcomes of 6-day emergency readmission following day-case endoscopy. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 24(12), 1438-1446. doi:10.1097/MEG.0b013e3283582db0
The Effect of High Quality Assurance Measures in Bowel Cancer Screening on Patient Satisfaction of Colonoscopy
Sarkar, S., Athwal, V., Sturgess, R. P., Lythgoe, D., & Bodger, K. (2012). The Effect of High Quality Assurance Measures in Bowel Cancer Screening on Patient Satisfaction of Colonoscopy. JOURNAL OF GASTROINTESTINAL AND LIVER DISEASES, 21(3), 251-258. Retrieved from https://www.webofscience.com/
Inequalities in outcomes of acute kidney injury in England
Abraham, K. A., Thompson, E. B., Bodger, K., & Pearson, M. (2012). Inequalities in outcomes of acute kidney injury in England. QJM-AN INTERNATIONAL JOURNAL OF MEDICINE, 105(8), 729-740. doi:10.1093/qjmed/hcs037
Gastrointestinal Bleeding
Bodger, K. (2012). Gastrointestinal Bleeding. In M. G. Gosney, A. Harper, & S. Conroy (Eds.), Oxford Desk Reference - Geriatric Medicine (pp. TBC). Oxford: Oxford University Press.
Gastroscopy rate in English general practice populations: association with outcome for oesophagogastric cancer
Shawihdi, M., Powell, G., Stern, N., Kapoor, N., Sturgess, R., Thompson, E., . . . Bodger, K. (2012). Gastroscopy rate in English general practice populations: association with outcome for oesophagogastric cancer. Gut, 61((Suppl), A19.
Medical resource utilisation and costs in patients with ulcerative colitis in the UK: a chart review analysis
Bodger, K., Yen, L., Szende, A., Sharma, G., McDermott, J., Chen, J. Y., & Hodgkins, P. (2012). Medical resource utilisation and costs in patients with ulcerative colitis in the UK: a chart review analysis. Gut, 61((Suppl), A223-A224.
National study of outcomes for cholangiocarcinoma patients following biliary endoscopy: linkage analysis of administrative data for English hospitals (2006-2008)
Polavarapu, N., Bowering, K., Thompson, E., Sturgess, R., Pearson, M., & Bodger, K. (2012). National study of outcomes for cholangiocarcinoma patients following biliary endoscopy: linkage analysis of administrative data for English hospitals (2006-2008). Gut, 61((Suppl), A220.
Prognostic indicators for short and long-term outcomes of colorectal endoscopic mucosal resection (EMR): a multi-centre (CERT-n) study
Geraghty, J., Bodger, K., Alam, S., Jafar, W., Gillon, M., Babbs, C., . . . Sarkar, S. (2012). Prognostic indicators for short and long-term outcomes of colorectal endoscopic mucosal resection (EMR): a multi-centre (CERT-n) study. Gut, 61((Suppl), 6-7.
Secondary care costs in oesophagogastric cancer in the UK: a single centre micro-costing study
Stern, N., Bassi, A., & Bodger, K. (2012). Secondary care costs in oesophagogastric cancer in the UK: a single centre micro-costing study. Gut, 61((Suppl), A305.
Self expandable metal stents (SEMS) for obstructing colorectal cancer in England: linkage analysis of hospital episode statistics
Geraghty, J., Sarkar, S., Shawihdi, M., Thompson, E., Pearson, M., & Bodger, K. (2012). Self expandable metal stents (SEMS) for obstructing colorectal cancer in England: linkage analysis of hospital episode statistics. Gut, 61((Suppl), A272-A273.
The IBD-Control Questionnaire: Development and Psychometric Validation of a Tool for Capturing Disease Control From the Patient Perspective for use in Routine Care
Ormerod, C., Shackcloth, D., Harrison, M., Brown, E., & Bodger, K. (2012). The IBD-Control Questionnaire: Development and Psychometric Validation of a Tool for Capturing Disease Control From the Patient Perspective for use in Routine Care. Gastroenterology, 142(5 (Sup), S-658.
The IBD-control questionnaire: development and psychometric validation of a tool for capturing disease control from the patient perspective for use in routine care
Ormerod, C., Shackcloth, D., Harrison, M., Brown, E., & Bodger, K. (2012). The IBD-control questionnaire: development and psychometric validation of a tool for capturing disease control from the patient perspective for use in routine care. Gut, 61((Suppl), A173.
The UK inflammatory bowel disease audit: key findings from the inpatient experience questionnaire
Bodger, K., Arnott, I., Down, C., Driscoll, R., Protheroe, A., & Roughton, M. (2012). The UK inflammatory bowel disease audit: key findings from the inpatient experience questionnaire. Gut, 61((Suppl), A224.
The effect of high quality assurance measures in bowel cancer screening on patient satisfaction of colonoscopy
Sarkar, S., Athwal, V., Sturgess, R. P., & Lythgoe, D. (2012). The effect of high quality assurance measures in bowel cancer screening on patient satisfaction of colonoscopy. J Gastrointestin Liver Disease, 21(3), 251-258.
The impact of surgery on health related quality of life in ulcerative colitis
Swinburn, P., Elwick, H., Bean, K., Curry, A., Patel, A., Bodger, K., & Lloyd, A. (2012). The impact of surgery on health related quality of life in ulcerative colitis. Gut, 61((Suppl), A237.
2011
All-cause mortality after first ERCP in England: clinically guided analysis of hospital episode statistics with linkage to registry of death
Bodger, K., Bowering, K., Sarkar, S., Thompson, E., & Pearson, M. G. (2011). All-cause mortality after first ERCP in England: clinically guided analysis of hospital episode statistics with linkage to registry of death. GASTROINTESTINAL ENDOSCOPY, 74(4), 825-833. doi:10.1016/j.gie.2011.06.007
A pragmatic randomized controlled trial of thiopurine methyltransferase genotyping prior to azathioprine treatment: the TARGET study
Newman, W. G., Payne, K., Tricker, K., Roberts, S. A., Fargher, E., Pushpakom, S., . . . Ollier, W. E. R. (2011). A pragmatic randomized controlled trial of thiopurine methyltransferase genotyping prior to azathioprine treatment: the TARGET study. PHARMACOGENOMICS, 12(6), 815-826. doi:10.2217/PGS.11.32
Cost Effectiveness of Treatments for Inflammatory Bowel Disease
Bodger, K. (2011). Cost Effectiveness of Treatments for Inflammatory Bowel Disease. PHARMACOECONOMICS, 29(5), 387-401. doi:10.2165/11584820-000000000-00000
30-Day COPD readmissions relate to disease severity and demographic factors rather than simply organisation and delivery of hospital care
Hare, J., Thompson, E., Bodger, K., Walker, P., & Pearson, M. (2011). 30-Day COPD readmissions relate to disease severity and demographic factors rather than simply organisation and delivery of hospital care. Thorax, 66((Suppl), A107-A108.
An evaluation of the impact of biologic therapy on secondary care resource use associated with the management of crohn's disease in the UK
Lindsay, J. O., Bloom, S., Hamlin, P. J., Hayward, C., Percival, F., Bean, K., & Bodger, K. (2011). An evaluation of the impact of biologic therapy on secondary care resource use associated with the management of crohn's disease in the UK. Gut, 60((Suppl), A214.
Emergency Hospital Admission as a Route for Oesophagogastric Cancer Diagnosis: A Marker of Poor Outcome and a Candidate Quality Indicator for Local Services
Shawihdi, M., Stern, N., Thompson, E., Sturgess, R., Kapoor, N., Pearson, M. G., & Bodger, K. (2011). Emergency Hospital Admission as a Route for Oesophagogastric Cancer Diagnosis: A Marker of Poor Outcome and a Candidate Quality Indicator for Local Services. Gastroenterology, 140(5 (Sup), S-207.
2010
PTU-022 atisfaction with healthcare in outpatients with gastrointestinal diseases: validation of a survey instrument and influence of patient characteristics
Anim-Somuah, K., Brailsford, F., Luces, C., & Bodger, K. (2010). PTU-022 atisfaction with healthcare in outpatients with gastrointestinal diseases: validation of a survey instrument and influence of patient characteristics. Gut, 59(Suppl 1), A57.1-A57. doi:10.1136/gut.2009.209031h
A cost-effectiveness analysis of MMX mesalazine compared with mesalazine in the treatment of mild-to-moderate ulcerative colitis from a UK perspective.
Brereton, N., Bodger, K., Kamm, M. A., Hodgkins, P., Yan, S., & Akehurst, R. (2010). A cost-effectiveness analysis of MMX mesalazine compared with mesalazine in the treatment of mild-to-moderate ulcerative colitis from a UK perspective.. Journal of medical economics, 13(1), 148-161. doi:10.3111/13696990903562861
All-Cause Mortality Following First Endoscopic Retrograde Cholangiopancreatography (ERCP) in England: Analysis of Hospital Episode Statistics Linked to Death Registration Data (2006-8)
Bodger, K., & al, E. (2010). All-Cause Mortality Following First Endoscopic Retrograde Cholangiopancreatography (ERCP) in England: Analysis of Hospital Episode Statistics Linked to Death Registration Data (2006-8). Gastroenterology, 5(Supp(138), S637.
All-Cause Mortality Following Percutaneous Endoscopic Gastrostomy (PEG) in England: Analysis of Hospital Episode Statistics Linked to Death Registration Data (2006-8)
Bodger, K., & al, E. (2010). All-Cause Mortality Following Percutaneous Endoscopic Gastrostomy (PEG) in England: Analysis of Hospital Episode Statistics Linked to Death Registration Data (2006-8). Gastroenterology, 5(Supp(138), S637.
All-cause mortality following percutaneous endoscopic gastrostomy in England: Analysis of hospital episode statistics linked to death registration data (2006-8)
Bodger, K., & al, E. (2010). All-cause mortality following percutaneous endoscopic gastrostomy in England: Analysis of hospital episode statistics linked to death registration data (2006-8). Gut, 59(Sup, A24.
Satisfaction With Healthcare in Outpatients With Gastrointestinal Diseases: Validation of an Instrument and Influence of Patient Characteristics on Ratings
Anim-Somuah, K., Brailsford, F., Luces, C., & Bodger, K. (2010). Satisfaction With Healthcare in Outpatients With Gastrointestinal Diseases: Validation of an Instrument and Influence of Patient Characteristics on Ratings. Gastroenterology, 5(Supp(138), S482.
2009
Cost-effectiveness of biological therapy for Crohn's disease: Markov cohort analyses incorporating United Kingdom patient-level cost data
Bodger, K., Kikuchi, T., & Hughes, D. (2009). Cost-effectiveness of biological therapy for Crohn's disease: Markov cohort analyses incorporating United Kingdom patient-level cost data. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 30(3), 265-274. doi:10.1111/j.1365-2036.2009.04033.x
Safer sedation practice may not translate into improvements in endoscopic outcomes
Sarkar, S., Bowering, K., Azim, W., & Bodger, K. (2009). Safer sedation practice may not translate into improvements in endoscopic outcomes. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 21(5), 534-543. doi:10.1097/MEG.0b013e32831bed96
All-cause mortality following endoscopic retrograde cholangiopancreatography in England
Bodger, K., Bowering, K., Sarkar, S., Grant-Pearce, C., Thompson, E., & Pearson, M. (2009). All-cause mortality following endoscopic retrograde cholangiopancreatography in England. Gut, 58((Suppl), A34.
Anti-TNFα therapies in the management of Crohn's disease
Bodger, K., Ghosh, S., & Hamlin, J. (2009). Anti-TNFα therapies in the management of Crohn's disease. Prescriber (Supplement), 1-12.
Gastroenterology
Hamilton, W., & Bodger, K. (2009). Gastroenterology. In M. Gosney, & T. Harris (Eds.), Managing Older People in Primary Care: A practical guide (pp. 89-100). Oxford: Oxford University Press.
Understanding variation in hospital length of stay
Bodger, K., Grant-Pearce, C., Thompson, E., Lowe, D., & Pearson, M. (2009). Understanding variation in hospital length of stay. Gut, 58((Suppl), A21.
Who looks after patients when they are hospitalised as an emergency: national-level analysis of a specialist gastroenterological condition
Bodger, K., Grant-Pearce, C., Thompson, E., Lowe, D., & Pearson, M. (2009). Who looks after patients when they are hospitalised as an emergency: national-level analysis of a specialist gastroenterological condition. Gut, 58((Suppl), A65.
2008
The cost-utility of high dose oral mesalazine for moderately active ulcerative colitis
Buckland, A., & Bodger, K. (2008). The cost-utility of high dose oral mesalazine for moderately active ulcerative colitis. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 28(11-12), 1287-1296. doi:10.1111/j.1365-2036.2008.03856.x
Altered gastric corpus expression of tissue inhibitors of metalloproteinases in human and murine <i>Helicobacter</i> infection
Bodger, K., Ahmed, S., Pazmany, L., Pritchard, D. M., Micheal, A., Khan, A. L., . . . Varro, A. (2008). Altered gastric corpus expression of tissue inhibitors of metalloproteinases in human and murine <i>Helicobacter</i> infection. JOURNAL OF CLINICAL PATHOLOGY, 61(1), 72-78. doi:10.1136/jcp.2007.048058
Altered gastric corpus expression of tissue inhibitors of metalloproteinases in human and murine<i>Helicobacter</i>infection
Bodger, K., Ahmed, S., Pazmany, L., Pritchard, D. M., Micheal, A., Khan, A. L., . . . Varro, A. (2008). Altered gastric corpus expression of tissue inhibitors of metalloproteinases in human and murine<i>Helicobacter</i>infection. Journal of Clinical Pathology, 61(1), 72-78. doi:10.1136/jcp.2007.048058
Fast-Track Services for Upper GI Cancer: Target: A Patient Screening Tool to Detect Delayed and Inappropriate 'Two Week Rule' Referrals and a Survey of Family Practitioner Preferences for Service Organisation
Pritchard, G., Kapoor, N., Sturgess, R., & Bodger, K. (2008). Fast-Track Services for Upper GI Cancer: Target: A Patient Screening Tool to Detect Delayed and Inappropriate 'Two Week Rule' Referrals and a Survey of Family Practitioner Preferences for Service Organisation. Gastroenterology, 134(4), A618.
The cost-effectiveness of biological therapies for crohn's disease: markov cohort analyses incorporating uk patient-level cost data
Bodger, K., Kikuchi, T., & Hughes, D. A. (2008). The cost-effectiveness of biological therapies for crohn's disease: markov cohort analyses incorporating uk patient-level cost data. GUT, 57, A48. Retrieved from https://www.webofscience.com/
2007
Increased gastric expression of MMP-7 in hypergastrinemia and significance for epithelial-mesenchymal signaling
Varro, A., Kenny, S., Hemers, E., McCaig, C., Przemeck, S., Wang, T. C., . . . Pritchard, D. M. (2007). Increased gastric expression of MMP-7 in hypergastrinemia and significance for epithelial-mesenchymal signaling. AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY, 292(4), G1133-G1140. doi:10.1152/ajpgi.00526.2006
A cost effectiveness analysis of high dose oral mesalazine for the treatment of moderately active ulcerative colitis: A decision-analytic model
Borrill, J., Bodger, K., & Bhatt, A. (2007). A cost effectiveness analysis of high dose oral mesalazine for the treatment of moderately active ulcerative colitis: A decision-analytic model. Gastroenterology, 132(4 (Sup), NN.
Biological agents for the management of Crohn's disease in adults: a systematic review, meta-analysis and multiple treatment comparison
Kikuchi, T., Bodger, K., & Hughes, D. A. (2007). Biological agents for the management of Crohn's disease in adults: a systematic review, meta-analysis and multiple treatment comparison. International Society for Pharmacoeconomics and Outcomes Research (ISPOR), NN, NN.
Health state utilities & willingness-to-pay in Inflammatory Bowel Disease (IBD) - a study of feasibility & validity
Bassi, A., & Bodger, K. (2007). Health state utilities & willingness-to-pay in Inflammatory Bowel Disease (IBD) - a study of feasibility & validity. Gastroenterology, 132(4 (Sup), NN.
Oesophageal cancer survival according to route of diagnosis: Impact of the United Kingdom 'Two Week Rule' and Barrett's Surveillance in a Tertiary Cancer Centre
Stern, N., Kapoor, N., Sturgess, R., & Bodger, K. (2007). Oesophageal cancer survival according to route of diagnosis: Impact of the United Kingdom 'Two Week Rule' and Barrett's Surveillance in a Tertiary Cancer Centre. Gastroenterology, 132(Suppl), NN.
Patient access times and survival before and after introduction of a Rapid Access Upper Gastrointestinal Cancer Service
Stern, N., Kapoor, N., Sturgess, R., & Bodger, K. (2007). Patient access times and survival before and after introduction of a Rapid Access Upper Gastrointestinal Cancer Service. Gut, 56(Suppl), A145.
Risk factors for Barrett's oesophagus among middle-aged men with reflux disease: a case-control study
Stern, N., & Bodger, K. (2007). Risk factors for Barrett's oesophagus among middle-aged men with reflux disease: a case-control study. Gut, 56(Supple), A145.
Satisfaction with healthcare in inflammatory bowel disease: influence of patient characteristics
Luces, C., Brown, E., & Bodger, K. (2007). Satisfaction with healthcare in inflammatory bowel disease: influence of patient characteristics. Gastroenterology, 132(4 (Sup), NN.
2006
Economic burden of inflammatory bowel disease: a UK perspective.
Luces, C., & Bodger, K. (2006). Economic burden of inflammatory bowel disease: a UK perspective.. Expert review of pharmacoeconomics & outcomes research, 6(4), 471-482. doi:10.1586/14737167.6.4.471
Altered colonic glycoprotein expression in unaffected monozygotic twins of inflammatory bowel disease patients
Bodger, K., Halfvarson, J., Dodson, A. R., Campbell, F., Wilson, S., Lee, R., . . . Rhodes, J. M. (2006). Altered colonic glycoprotein expression in unaffected monozygotic twins of inflammatory bowel disease patients. GUT, 55(7), 973-977. doi:10.1136/gut.2005.086413
A comparison of multivariable regression models to analyse cost data
Dodd, S., Bassi, A., Bodger, K., & Williamson, P. (2006). A comparison of multivariable regression models to analyse cost data. JOURNAL OF EVALUATION IN CLINICAL PRACTICE, 12(1), 76-86. doi:10.1111/j.1365-2753.2006.00610.x
A comparison of multivariable regression models to analyse cost data
Dodd, S., Bassi, A., Bodger, K., & Williamson, P. (2006). A comparison of multivariable regression models to analyse cost data. Journal of Evaluation in Clinical Practice, 12(1), 76-86.
The role of matrix metalloproteinase-7 in redefining the gastric microenvironment in response to <i>Helicobacter pylori</i>
McCaig, C., Duval, C., Hemers, E., Steele, I., Pritchard, D. M., Przemeck, S., . . . Varro, A. (2006). The role of matrix metalloproteinase-7 in redefining the gastric microenvironment in response to <i>Helicobacter pylori</i>. GASTROENTEROLOGY, 130(6), 1754-1763. doi:10.1053/j.gastro.2006.02.031
2005
Economic analysis of on-demand maintenance therapy with proton pump inhibitors in patients with non-erosive reflux disease
Hughes, D. A., Bodger, K., Bytzer, P., de Herdt, D., & Dubois, D. (2005). Economic analysis of on-demand maintenance therapy with proton pump inhibitors in patients with non-erosive reflux disease. PHARMACOECONOMICS, 23(10), 1031-1041. doi:10.2165/00019053-200523100-00006
Economic implications of biological therapies for Crohn's disease - Review of infliximab
Bodger, K. (2005). Economic implications of biological therapies for Crohn's disease - Review of infliximab. PHARMACOECONOMICS, 23(9), 875-888. doi:10.2165/00019053-200523090-00002
Predictive value of alarm features in a rapid access upper gastrointestinal cancer service
Kapoor, N., Bassi, A., Sturgess, R., & Bodger, K. (2005). Predictive value of alarm features in a rapid access upper gastrointestinal cancer service. GUT, 54(1), 40-45. doi:10.1136/gut.2004.039438
2004
Cost of illness of inflammatory bowel disease in the UK: a single centre retrospective study
Bassi, A., Dodd, S., Williamson, P., & Bodger, K. (2004). Cost of illness of inflammatory bowel disease in the UK: a single centre retrospective study. GUT, 53(10), 1471-1478. doi:10.1136/gut.2004.041616
2003
Detection of sulfated glycoproteins in intestinal metaplasia:: a comparison of traditional mucin staining with immunohistochemistry for the sulfo-Lewis<SUP>a</SUP> carbohydrate epitope
Bodger, K., Campbell, F., & Rhodes, J. M. (2003). Detection of sulfated glycoproteins in intestinal metaplasia:: a comparison of traditional mucin staining with immunohistochemistry for the sulfo-Lewis<SUP>a</SUP> carbohydrate epitope. JOURNAL OF CLINICAL PATHOLOGY, 56(9), 703-708. doi:10.1136/jcp.56.9.703
2002
Dissatisfaction with consent for diagnostic gastrointestinal endoscopy
Bassi, A., Brown, E., Kapoor, N., & Bodger, K. (2002). Dissatisfaction with consent for diagnostic gastrointestinal endoscopy. DIGESTIVE DISEASES, 20(3-4), 275-279. doi:10.1159/000067680
Cost of illness of Crohn's disease
Bodger, K. (2002). Cost of illness of Crohn's disease. PHARMACOECONOMICS, 20(10), 639-652. doi:10.2165/00019053-200220100-00001
2001
Variation in serum pepsinogens with severity and topography of <i>Helicobacter pylori</i>-associated chronic gastritis in dyspeptic patients referred for endoscopy
Bodger, K., Wyatt, J. I., & Heatley, R. V. (2001). Variation in serum pepsinogens with severity and topography of <i>Helicobacter pylori</i>-associated chronic gastritis in dyspeptic patients referred for endoscopy. HELICOBACTER, 6(3), 216-224. doi:10.1046/j.1523-5378.2001.00031.x
Interleukin 10 in <i>Helicobacter pylori</i> associated gastritis:: immunohistochemical localisation and in vitro effects on cytokine secretion
Bodger, K., Bromelow, K., Wyatt, J. I., & Heatley, R. V. (2001). Interleukin 10 in <i>Helicobacter pylori</i> associated gastritis:: immunohistochemical localisation and in vitro effects on cytokine secretion. JOURNAL OF CLINICAL PATHOLOGY, 54(4), 285-292. doi:10.1136/jcp.54.4.285
The immune system and nutrition support
Bodger, K., & Heatley, R. V. (2001). The immune system and nutrition support. In J. Payne-James, G. K. Grimble, & D. B. A. Silk (Eds.), Artificial Nutrition Support in Clinical Practice (pp. 137-148). London: Greenwich Medical Media Ltd.
2000
Dyspepsia workload in urban general practice and implications of the British Society of Gastroenterology Dyspepsia Guidelines (1996)
Bodger, K., Eastwood, P. G., Manning, S. I., Daly, M. J., & Heatley, R. V. (2000). Dyspepsia workload in urban general practice and implications of the British Society of Gastroenterology Dyspepsia Guidelines (1996). ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 14(4), 413-420. Retrieved from https://www.webofscience.com/
Colorectal cancer.
Bodger, K. (2000). Colorectal cancer.. Journal of the Royal College of Physicians of London, 34(2), 197-201.
Clinical Economics in Gastroenterology
Bodger, K., Daly, M., & Heatley, R. V. (Eds.) (2000). Clinical Economics in Gastroenterology. Oxford: Blackwell Science Ltd.
Counting the costs of dyspepsia
Bodger, K., & Heatley, R. V. (2000). Counting the costs of dyspepsia. In R. V. Heatley, & P. Moncur (Eds.), Dyspepsia: The Clinical Consequences (pp. 273-290). Oxford: Blackwell Science Ltd.
Pathogenesis, diagnosis and treatment of dyspepsia
Bodger, K. (2000). Pathogenesis, diagnosis and treatment of dyspepsia. (PhD Thesis, The University of Leeds).
1999
Serologic screening before endoscopy:: The value of <i>Helicobacter pylori</i> serology, serum recognition of the CagA and VacA proteins, and serum pepsinogen I
Bodger, K., Wyatt, J. I., & Heatley, R. V. (1999). Serologic screening before endoscopy:: The value of <i>Helicobacter pylori</i> serology, serum recognition of the CagA and VacA proteins, and serum pepsinogen I. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 34(9), 856-863. Retrieved from https://www.webofscience.com/
Clinical economics review: medical management of inflammatory bowel disease
Ward, F. M., Bodger, K., Daly, M. J., & Heatley, R. V. (1999). Clinical economics review: medical management of inflammatory bowel disease. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 13(1), 15-25. Retrieved from https://www.webofscience.com/
Serological screening before endoscopy: the value of Helicobacter pylori serology, serum recognition of the vacA and cagA proteins and serum pepsinogen I
Bodger, K., Wyatt, J. I., & Heatley, R. V. (1999). Serological screening before endoscopy: the value of Helicobacter pylori serology, serum recognition of the vacA and cagA proteins and serum pepsinogen I. Scandinavian J Gastroenterology, 13(1), 15-25.
1998
The pathogenic role of Helicobacter pylori in peptic ulcer disease and non-ulcer dyspepsia.
Heatley, R. V., & Bodger, K. (1998). The pathogenic role of Helicobacter pylori in peptic ulcer disease and non-ulcer dyspepsia.. Saudi journal of gastroenterology : official journal of the Saudi Gastroenterology Association, 4(3), 137.
<i>Helicobacter pylori</i> and gastric inflammation
Bodger, K., & Crabtree, J. E. (1998). <i>Helicobacter pylori</i> and gastric inflammation. BRITISH MEDICAL BULLETIN, 54(1), 139-150. Retrieved from https://www.webofscience.com/
1997
Gastric mucosal secretion of interleukin-10: Relations to histopathology, Helicobacter pylori status, and tumour necrosis factor-alpha secretion
Badger, K., Wyatt, J. I., & Heatley, R. V. (1997). Gastric mucosal secretion of interleukin-10: Relations to histopathology, Helicobacter pylori status, and tumour necrosis factor-alpha secretion. GUT, 40(6), 739-744. doi:10.1136/gut.40.6.739
Clinical economics review: Helicobacter pylori-associated peptic ulcer disease
Bodger, K., Daly, M. J., & Heatley, R. V. (1997). Clinical economics review: Helicobacter pylori-associated peptic ulcer disease. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 11(2), 273-282. doi:10.1046/j.1365-2036.1997.145321000.x
1996
Testing to check success of treatment to eradicate H-pylori - Patients' wellbeing should not be risked for marginal cost savings
Bodger, K., & Heatley, R. V. (1996). Testing to check success of treatment to eradicate H-pylori - Patients' wellbeing should not be risked for marginal cost savings. BRITISH MEDICAL JOURNAL, 312(7042), 1361-1362. doi:10.1136/bmj.312.7042.1361b
Clinical economics review: Gastroenterology
Bodger, K., Daly, M. J., Heatley, R. V., & Williams, D. R. R. (1996). Clinical economics review: Gastroenterology. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 10(1), 55-60. Retrieved from https://www.webofscience.com/
Clinical economics review: gastroenterology
Bodger, K., Daly, M. J., Heatley, R. V., & Williams, D. R. (1996). Clinical economics review: gastroenterology. Unknown Journal, 10(1), 55-60.
Prescribing patients for dyspepsia in primary care: A prospective study of selected general practitioners
Bodger, K., Daly, M. J., & Heatley, R. V. (1996). Prescribing patients for dyspepsia in primary care: A prospective study of selected general practitioners. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 10(6), 889-895. doi:10.1046/j.1365-2036.1996.107278000.x